FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Amazon Explores AI Content Marketplace With Media Publishers 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Toronto, April 06, 2018 --
TORONTO—April 6, 2018—Galileo Global Equity Advisors, Inc., a privately owned investment manager based in Toronto, today would like to comment on a correction in an April 6 System for Electronic Disclosure by Insiders (SEDI) filing that showed a change to the holdings of insider Frank E. Holmes in HIVE Blockchain Technologies, Ltd. (CVE: HIVE).
Galileo would like to clarify that the shares were not disposed of by Holmes. These shares have always been registered to the Galileo Partners Fund, which purchased the HIVE shares and warrants in September 2017. The securities were originally reported to be held by Holmes himself, and in clarifying this on SEDI, the reporting was rectified.
Galileo is a 65-percent owned subsidiary of U.S. Global Investors, Inc. (NASDAQ: GROW), a boutique investment firm based in San Antonio, Texas, for which Holmes serves as CEO and chief investor officer. In addition, Holmes was appointed as the non-executive chairman of the Board of Directors of HIVE.
About Galileo Global Equity Advisors, Inc.
Since its founding in 2000, Galileo Global Equity Advisors, Inc. (www.galileofunds.ca), a privately owned investment manager, has had a singular mission of helping its clients achieve their long-term investment objectives by delivering superior risk-adjusted returns. Headquartered in Toronto, Galileo seeks to identify and invest in the most promising small and mid-cap companies before they become widely followed by mainstream analysts. One of the hallmarks of Galileo’s approach is that it takes a contrarian, businesslike approach to investing in smaller and medium sized companies.
# # # # #
|
|||
Evelyn Foo Galileo Global Equity Advisors 416-594-0600 [email protected]
